Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices

This study assessed the total costs of testing, including the estimated costs of delaying care, associated with next-generation sequencing (NGS) versus single-gene testing strategies among patients with newly diagnosed metastatic non-small cell lung cancer (mNSCLC) from a Canadian public payer persp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheffield, Brandon S., Eaton, Kiefer, Emond, Bruno, Lafeuille, Marie-Hélène, Hilts, Annalise, Lefebvre, Patrick, Morrison, Laura, Stevens, Andrea L., Ewara, Emmanuel M., Cheema, Parneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955559/
https://www.ncbi.nlm.nih.gov/pubmed/36826141
http://dx.doi.org/10.3390/curroncol30020180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955559/
https://www.ncbi.nlm.nih.gov/pubmed/36826141
http://dx.doi.org/10.3390/curroncol30020180

Ejemplares similares